Science

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang/LinkedIn

Mar 4, 2025, 05:27

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang, Professor of Microbiology, Immunology and Molecular Genetics at University of California, Los Angeles (UCLA), shared her recent article on LinkedIn:

“January 17, 2025- Our protocol article is published on Nature Protocols, reporting generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture.

Congratulations to all the authors, in particular the co-first authors Yan-Ruide (Charlie) Li, Kuangyi (Coin) Zhou, and Derek Lee!”

Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture

Authors: Yan-Ruide Li, et al.

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

allogeneic cancer CAR-NKT cells Derek Lee fight against cancer Global fight against cancer immunology immunotherapy Kuangyi (Coin) Zhou Lili Yang Microbiology Molecular Genetics Nature Protocols OncoDaily Oncology UCLA University of California Yan-Ruide (Charlie) Li

Uhm Jung-hwa: Korea’s Iconic ‘Madonna’ and Her Triumphant Battle Against Thyroid Cancer

Vincent Rajkumar: A Historic Day for High Risk Smoldering Myeloma

Dr. Anastasia Constantinidou Nominated for Madame Figaro Woman of the Year 2025

Lisa A. Lacasse Welcomed Shane Jacobson as the New CEO of the ACS and the ACS CAN

ASCO and Community Oncology Alliance Have Released the Updated Oncology Medical Home Standards